OPKO Health
OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137
Phone: (305) 575 4100Website: https://www.opko.com/Careers: www.opko.com/careers
Latest news
- FDA Approves Rayaldee (calcifediol) to Treat Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
21 June 2016 - FDA Accepts Resubmission of New Drug Application for Rayaldee
27 April 2016 - OPKO Receives Complete Response Letter from FDA for Rayaldee New Drug Application
30 March 2016 - FDA Accepts OPKO's New Drug Application for Rayaldee
28 July 2015 - OPKO Announces Submission of Rayaldee NDA
2 June 2015
Drugs Associated with OPKO Health, Inc.
OPKO Health, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Rayaldee
Generic name: calcifediol Drug class: vitamins |
6 reviews | 7.5 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||